Glob Bioenergi Financials
| ALGBE Stock | EUR 0.87 0.04 4.82% |
Glob |
Understanding current and past Glob Bioenergi Financials, including the trends in assets, liabilities, equity and income are directly related to making proper and timely investing decisions. All of Glob Bioenergi's financial statements are interrelated, with each one affecting the others. For example, an increase in Glob Bioenergi's assets may result in an increase in income on the income statement.
Glob Bioenergi Stock Summary
Glob Bioenergi competes with Voltalia, Ecoslops, Agripower France, Enertime SAS. Global Bioenergies SA focuses on the development of a biological process for converting renewable resources into isobutene. Global Bioenergies SA was founded in 2008 and is headquartered in Evry, France. GLOBAL BIOENERGIES operates under Utilities - Diversified classification in France and is traded on Paris Stock Exchange. It employs 54 people.| Instrument | France Stock View All |
| Exchange | Euronext Paris |
| ISIN | FR0011052257 |
| Business Address | 5, rue Henri |
| Sector | Chemicals |
| Industry | Materials |
| Benchmark | Dow Jones Industrial |
| Website | www.global-bioenergies.com |
| Phone | 33 1 64 98 20 50 |
| Currency | EUR - Euro |
You should never invest in Glob Bioenergi without having analyzed its financial statements. Do not rely on someone else's analysis or guesses about the future performance of Glob Stock, because this is throwing your money away. Analyzing the key information contained in Glob Bioenergi's financial statements can give you an edge over other investors and help to ensure that your investments perform well for you.
Glob Bioenergi Key Financial Ratios
Glob Bioenergi's financial ratios allow both analysts and investors to convert raw data from Glob Bioenergi's financial statements into concise, actionable information that can be used to evaluate the performance of Glob Bioenergi over time and compare it to other companies across industries.Glob Financial Ratios Relationships
Comparative valuation techniques use various fundamental indicators to help in determining Glob Bioenergi's current stock value. Our valuation model uses many indicators to compare Glob Bioenergi value to that of its competitors to determine the firm's financial worth. You can analyze the relationship between different fundamental ratios across Glob Bioenergi competition to find correlations between indicators driving Glob Bioenergi's intrinsic value. More Info.Glob Bioenergi is rated third in return on equity category among its peers. It also is rated third in return on asset category among its peers . The reason why the comparable model can be used in almost all circumstances is due to the vast number of multiples that can be utilized, such as the price-to-earnings (P/E), price-to-book (P/B), price-to-sales (P/S), price-to-cash flow (P/CF), and many others. The P/E ratio is the most commonly used of these ratios because it focuses on the Glob Bioenergi's earnings, one of the primary drivers of an investment's value.Glob Bioenergi Systematic Risk
Glob Bioenergi's systematic risk plays a vital role in portfolio allocation when considering its stock to be added to a well-diversified portfolio. Glob Bioenergi volatility which cannot be eliminated through diversification, requires returns over the risk-free rate. Over the long run, a well-diversified portfolio provides returns that match its exposure to systematic risk. In this case, investors face a trade-off between expected returns and systematic risk and, therefore, can only reduce a portfolio's exposure to systematic risk by sacrificing expected returns on the portfolio.
The output start index for this execution was ten with a total number of output elements of fifty-one. The Beta measures systematic risk based on how returns on Glob Bioenergi correlated with the market. If Beta is less than 0 Glob Bioenergi generally moves in the opposite direction as compared to the market. If Glob Bioenergi Beta is about zero movement of price series is uncorrelated with the movement of the benchmark. if Beta is between zero and one Glob Bioenergi is generally moves in the same direction as, but less than the movement of the market. For Beta = 1 movement of Glob Bioenergi is generally in the same direction as the market. If Beta > 1 Glob Bioenergi moves generally in the same direction as, but more than the movement of the benchmark.
Glob Bioenergi November 30, 2024 Opportunity Range
Along with financial statement analysis, the daily predictive indicators of Glob Bioenergi help investors to analyze its daily demand and supply, volume, patterns, and price swings to determine the real value of Glob Bioenergi. We use our internally-developed statistical techniques to arrive at the intrinsic value of Glob Bioenergi based on widely used predictive technical indicators. In general, we focus on analyzing Glob Stock price patterns and their correlations with different microeconomic environment and drivers. We also apply predictive analytics to build Glob Bioenergi's daily price indicators and compare them against related drivers.
| Information Ratio | (0.04) | |||
| Maximum Drawdown | 86.27 | |||
| Value At Risk | (16.38) | |||
| Potential Upside | 12.22 |
Additional Tools for Glob Stock Analysis
When running Glob Bioenergi's price analysis, check to measure Glob Bioenergi's market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy Glob Bioenergi is operating at the current time. Most of Glob Bioenergi's value examination focuses on studying past and present price action to predict the probability of Glob Bioenergi's future price movements. You can analyze the entity against its peers and the financial market as a whole to determine factors that move Glob Bioenergi's price. Additionally, you may evaluate how the addition of Glob Bioenergi to your portfolios can decrease your overall portfolio volatility.